Life After Chevron: User Fee Cycle May Help US FDA In Era Of Uncertainty
US federal agencies are entering a new era of uncertainty and increased litigation over their regulatory interpretations, but the FDA may benefit from the unique circumstances that have evolved through user fee legislation.
